Cardiovascular Therapeutics / 2019 / Article / Tab 1

Review Article

Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis

Table 1

Characteristics of the included studies.

Author (year)CountryPatient numberPAFMean ageMaleCADGal-3 methodCA detailsNumber of cases with AF recurrenceMean follow-upOutcomes reportedVariables adjustedNOS
%years%%months

Gurses (2014)Turkey100NR57440ELISACB-CPVI2412Baseline difference of Gal-3NA6 (3/2/1)
Lee (2014)China96100NRNRNRELISARF-CPVI3918Baseline difference of Gal-3 and risk estimation for AF recurrenceAge, gender, LAD, and NT-proBNP6 (3/2/1)
Wu (2015)China50049940ELISARF-CPVI Plus3212Baseline difference of Gal-3 and risk estimation for AF recurrenceAge, gender, and LAD9 (4/3/2)
Kornej (2015)Germany92516265NRELISARF-CPVI Plus366Baseline difference of Gal-3NA8 (4/2/2)
Takemoto (2016)US5553638215ELISARF-CPVI Plus1612Baseline difference of Gal-3 and risk estimation for AF recurrenceAge, gender, type of AF, and LAD9 (4/3/2)
Clementy (2016)France160556171NRELISARF-CPVI Plus5512Baseline difference of Gal-3 and risk estimation for AF recurrenceAge, gender, and LAD9 (4/3/2)
Begg (2018)UK926758605ELISARF-CPVI Plus4212Baseline difference of Gal-3NA9 (4/3/2)

AF, atrial fibrillation; PC, prospective cohort; PAF, paroxysmal AF; NR, not reported; Gal-3, galectin-3; CAD, coronary artery disease; CA, catheter ablation; CB, cryoballoon; RF, radiofrequency; CPVI, circumferential pulmonary vein isolation; CPVI plus, includes CPVI with one or more of adjuvant ablations in cavotricuspid isthmus, mitral isthmus, left atrial roof, the basal posterior wall, superior vena cava or complex fractionate atrial electrograms; ELISA, enzyme linked immunosorbent assay; LAD, left atrial dimension; NT-proBNP, N terminal pro B type natriuretic peptide; NOS, Newcastle-Ottawa Scale.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.